AMED
Undervalued by 6% based on the discounted cash flow analysis.
Market cap | $3.10 Billion |
---|---|
Enterprise Value | $3.39 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-0.63 |
Beta | 0.15 |
Outstanding Shares | 32,676,879 |
Avg 30 Day Volume | 236,771 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -150.67 |
---|---|
PEG | 350.7 |
Price to Sales | 1.39 |
Price to Book Ratio | 2.86 |
Enterprise Value to Revenue | 1.5 |
Enterprise Value to EBIT | 15.79 |
Enterprise Value to Net Income | -165 |
Total Debt to Enterprise | 0.12 |
Debt to Equity | 0.36 |
No data
No data